<DOC>
	<DOC>NCT02016235</DOC>
	<brief_summary>Patients with Dent disease have suppressed levels of FGF 23 which contributes to hypercalciuria, kidney stones, nephrocalcinosis and renal failure. Supplementation with phosphorus may reduce hypercalciuria.</brief_summary>
	<brief_title>Role Of Phosphorus And FGF 23 In Patients With Dent Disease</brief_title>
	<detailed_description />
	<mesh_term>Dent Disease</mesh_term>
	<criteria>1. Patients will be recruited from those in the RKSC Dent Registry Diagnostic criteria for Dent disease include: A. 1. LMWP (at least 5 times above the upper limit of normal) and at least 1 of the following criteria: 1. Hypercalciuria, 2. Kidney stones, 3. Nephrocalcinosis, 4. Hypophosphatemia, 5. Renal phosphate leak, 6. Aminoaciduria, 7. Glucosuria without diabetes mellitus, 8. Hematuria, 9. Renal insufficiency, 10. Family history with xlinked inheritance or B. 1 of the above criteria (19) and confirmed genetic mutation of CLCN5 or OCRL1. 2. Idiopathic calcium nephrolithiasis with renal phosphate leak 1. Male patients &gt; 18 years old 2. History of symptomatic calcium oxalate or calcium phosphate stone, hypercalciuria (&gt;250 mg/24 hrs), renal phosphate leak (TMP/GFR &lt;2.07 mg/dl) 3. Idiopathic calcium nephrolithiasis without renal phosphate leak 1. Male patients &gt; 18 years old 2. History of symptomatic calcium oxalate or calcium phosphate stone, hypercalciuria (&gt;250 mg/24 hrs), renal phosphate leak (TMP/GFR &lt;2.07 mg/dl) 1. Exclusion for Dent disease include: primary or secondary hyperparathyroidism, hyperthyroidism, chronic diarrhea states; intake of thiazide diuretics, glucocorticoids, or estrogens within one month of the study. 2. Exclusion criteria for calcium stone formers include: primary or secondary hyperparathyroidism, hyperthyroidism, estimated GFR &lt;40 ml/mn/1.73m2, chronic diarrhea states; intake of thiazide diuretics, glucocorticoids, or estrogens within one month of the study. 3. Exclusion criteria include history of symptomatic or asymptomatic kidney stone disease; primary or secondary hyperparathyroidism; estimated GFR &lt;40 ml/min/1.73m2, chronic diarrhea states; intake of thiazide diuretics, glucocorticoids, or estrogens within one month of the study.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dent</keyword>
	<keyword>Dents</keyword>
	<keyword>Dent Disease</keyword>
	<keyword>Phosphorus Supplements</keyword>
	<keyword>FGF 23</keyword>
</DOC>